Features - VJNeurology

Advances in early-stage multiple sclerosis

The 7th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) brought together experts to share the latest…

New stroke guidelines: MSUs for prehospital stroke management and IVT before MT in patients with acute ischemic stroke

The European Stroke Organisation (ESO) has published new guidelines for prehospital management of suspected stroke patients, and recommendations, in collaboration…

New in epilepsy: promising therapeutic strategies

New treatment strategies are gaining attention in epilepsy, where current therapeutic options are ineffective for many. Learn more about the…

Epstein-Barr virus may be the predominant trigger of multiple sclerosis

A record-breaking study into the relationship between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS) onset has revealed a 32-fold…

The present and future of biomarkers in MS

Biomarker research was a major talking point at ECTRIMS 2021. Discover the latest developments discussed at the meeting, from moving…

COVID-19 vaccination in patients with multiple sclerosis

Real-world data sets were presented at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),…

Key themes in Parkinson’s disease research in 2021

Learn more about the major research themes in Parkinson’s disease, discussed at the International Congress of Parkinson’s Disease and Movement…

Daridorexant under FDA & EMA review for insomnia after Phase III success

Insomnia is a common sleep disorder with a prevalence ranging from 5.8–20.0%1 and associated with various comorbidities and major societal…